Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK
暂无分享，去创建一个
Y. Agid | J. Laplanche | A. Alpérovitch | R. Will | P. Brown | J. Brandel | E. Croes | M. Preece
[1] M. Preece,et al. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959–85: a cohort study , 2002, The Lancet.
[2] L. McShane,et al. Iatrogenic Creutzfeldt–Jakob disease at the millennium , 2000, Neurology.
[3] J. Laplanche,et al. Molecular genetics of prion diseases in France , 1994, Neurology.
[4] N. Hunter,et al. PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie. , 1994, The Journal of general virology.
[5] John Collinge,et al. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease , 1991, Nature.